Sanofi (SNY) Assets (2009 - 2026)

Sanofi (SNY) posted Assets of $149.9 billion for Q1 2026, up 1.54% sequentially from $147.6 billion in Q4 2025, and up 8.04% YoY from $138.7 billion in Q1 2025.

Sanofi (SNY) Assets (2009 - 2026) Analysis & Trends

Sanofi (SNY) has 18 years of Assets data on file, last reported at $149.9 billion in Q1 2026.

  • Quarterly Assets rose 8.04% year-over-year to $149.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $149.9 billion (up 8.04% YoY) and the FY2025 annual result came in at $147.6 billion, up 4.02% from the prior year.
  • Assets rose to $149.9 billion in Q1 2026 per SNY's latest filing, from $147.6 billion in the prior quarter.
  • The five-year high for Assets was $151.7 billion in Q3 2025, with the low at $129.3 billion in Q4 2022.
  • Average Assets over 5 years is $140.3 billion, with a median of $139.7 billion recorded in 2024.
  • Year-over-year, Assets dropped 6.01% in 2022 and gained 8.04% in 2026.
  • Sanofi's Assets stood at $129.3 billion in 2022, then rose by 5.24% to $136.1 billion in 2023, then rose by 4.29% to $141.9 billion in 2024, then gained by 4.02% to $147.6 billion in 2025, then advanced by 1.54% to $149.9 billion in 2026.
  • Business Quant data shows SNY's Assets at $149.9 billion in Q1 2026, $147.6 billion in Q4 2025, and $151.7 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 116.58 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 200.89 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 136.46 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 114.02 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 128.69 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 92.50 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 56.28 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 208.00 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Sanofi - - 9.49 Bn 149.88 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 149.88 Bn
Dec 31, 2025 147.61 Bn
Sep 30, 2025 151.74 Bn
Jun 30, 2025 141.45 Bn
Mar 31, 2025 138.74 Bn
Dec 31, 2024 141.91 Bn
Jun 30, 2024 139.73 Bn
Dec 31, 2023 136.07 Bn
Jun 30, 2023 136.50 Bn
Dec 31, 2022 129.29 Bn
Jun 30, 2022 130.00 Bn
Dec 31, 2021 137.55 Bn
Jun 30, 2021 135.26 Bn
Dec 31, 2020 1.91 Bn
Jun 30, 2020 127.57 Bn
Dec 31, 2019 1.75 Bn
Jun 30, 2019 124.21 Bn
Dec 31, 2018 127.16 Bn
Sep 30, 2018 1.85 Bn
Jun 30, 2018 134.59 Bn